Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.

Breast cancer research and treatment - 1 Dec 2011

Harvey S L, Milne R L, McLachlan S A, Friedlander M L, Birch K E, Weideman P, Goldgar D, Hopper J L, Phillips K A

Abstract excerpt

Published studies have reached contradictory conclusions regarding breast cancer risk for women from families segregating a BRCA1 or BRCA2 mutation who do not carry the family-specific mutation. Accurate estimation of breast cancer risk is crucial for appropriate counselling regarding risk management. The aim of this study is to prospectively assess whether breast cancer risk for mutation negative women from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Incidence

Share to Risk Assessment

Share to Young Adult

Source

Identifiers

PMID: 21850394
DOI: 10.1007/s10549-011-1733-6

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.PMID 21850394Read ↗

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics.Semantic proximity Read ↗

No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families.Semantic proximity Read ↗

Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2.Semantic proximity Read ↗

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.Semantic proximity Read ↗

Cancer risks among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.Semantic proximity Read ↗

Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies.Semantic proximity Read ↗

Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.Semantic proximity Read ↗

Current perspectives on BRCA1- and BRCA2-associated breast cancers.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.